Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

NCT03767803 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2020-01-23

No results posted yet for this study

Summary

Whole blood sample procurement study from pregnant women with signs and symptoms of Preeclampsia.

Conditions

Interventions

OTHER

Non-interventional study

This is an observational, non-interventional study.

Sponsors & Collaborators

  • Progenity, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Stiegler, PhD · Progenity, Inc.

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767803 on ClinicalTrials.gov